SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

DORSAVI LTD (DVL)

Listed on ASX

SHARE PRICES

(updated weekly)

Former (or subsequent) names

 

Shareholder links

Our website ranking of DVL: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

Address: c/o Pitcher Partners, Level 13, 664 Collins Street, Docklands, Victoria, 3008
Tel:  1800 367 728 Fax: +61-(0)3-8610-1024

Date first listed: 11/12/2013
Company Secretary: Mr Brendan Case
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Medical research and development, supplying medical, sporting and occupational health and safety products, devices and services

The suspension of trading in the securities of dorsaVi Ltd will be lifted immediately, following the release by DVL of an announcement regarding a review of its operations and the raising of additional capital.

14/11/2019

A decision has been taken to further reduce cash expenses through both operational and staff related changes. The changes made in March 2019, and these new changes, have led to a reduction of 25% FTE equivalent headcount. There has also been a reduction in the salary of the CEO, Andrew Ronchi, in line with his original Australian based salary. The company's current cash and cash equivalents is now $1.66m. Total estimated cash outflows for this quarter remain at $1.58m of which $1.04m has already been paid. Cash receipts from operations for the current quarter are estimated to be approximately $0.6m of which $0.5m has been received. Whilst the operational changes will reduce the company's expenditure, the board has also resolved to raise further capital during the current quarter subject to market conditions. If a capital raising is unsuccessful the company will explore alternative options to achieve a cash flow neutral position.

14/11/2019

The securities of dorsaVi Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of DVL, pending the release of an announcement regarding the raising of additional capital.

11/11/2019

listed entity carried for record purposes only

11/12/2013

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    21/12/2018Andrew Ronchi3,200$0.058$186

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Caroline ElliottIndependent Director24/11/2017
    Andrew RonchiDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Andrew RonchiCEO07/05/201423/01/2018
    Herb ElliottNon Exec Chairman, Independent Director29/10/201323/11/2017
    Jerome WhelanCFO07/05/201412/10/2015

    Date of first appointment, title may have changed.